1. Home
  2. ALLT vs RCKT Comparison

ALLT vs RCKT Comparison

Compare ALLT & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Allot Ltd.

ALLT

Allot Ltd.

HOLD

Current Price

$7.73

Market Cap

408.0M

ML Signal

HOLD

Logo Rocket Pharmaceuticals Inc.

RCKT

Rocket Pharmaceuticals Inc.

HOLD

Current Price

$3.63

Market Cap

394.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALLT
RCKT
Founded
1996
1999
Country
Israel
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
408.0M
394.2M
IPO Year
2006
2014

Fundamental Metrics

Financial Performance
Metric
ALLT
RCKT
Price
$7.73
$3.63
Analyst Decision
Strong Buy
Buy
Analyst Count
6
14
Target Price
$12.40
$29.73
AVG Volume (30 Days)
243.1K
1.4M
Earning Date
05-12-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
26.37
EPS
N/A
0.66
Revenue
N/A
N/A
Revenue This Year
$15.84
N/A
Revenue Next Year
$12.09
$64.28
P/E Ratio
$469.21
$5.06
Revenue Growth
N/A
N/A
52 Week Low
$6.12
$2.53
52 Week High
$11.92
$5.45

Technical Indicators

Market Signals
Indicator
ALLT
RCKT
Relative Strength Index (RSI) 47.73 54.17
Support Level $7.41 $3.32
Resistance Level $8.51 $3.65
Average True Range (ATR) 0.37 0.19
MACD -0.00 0.00
Stochastic Oscillator 28.92 74.28

Price Performance

Historical Comparison
ALLT
RCKT

About ALLT Allot Ltd.

Allot Ltd is a provider of security and network intelligence solutions for mobile, fixed, and cloud service providers, as well as enterprises. It offers network-based security solutions such as mobile security, DDoS protection, and IoT security, along with network analytics and traffic management. It focuses on expanding its Security-as-a-Service (SECaaS) offerings through the Allot Secure product family, which delivers unified protection for consumers and SMBs across mobile, fixed, and 5G networks. Its Allot Smart solutions enable service providers to analyze and manage network data, optimize performance, reduce costs, and enhance user experience. It has a customer base in Europe, which generates maximum revenue, as well as in Asia and Oceania, the Americas, the Middle East, and Africa.

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.

Share on Social Networks: